PRISM Emerging Psychedelics

The World Health Organization has urged a change in global attitudes, actions and approaches to mental health. Unconventional methods for treatment could be the answer, according to biotech companies investigating the use of psychedelics to research solutions to treat depression, anxiety, PTSD, and other mental health conditions.

The PRISM Psychedelics Index tracks small and micro-cap stocks that are developing or marketing legal psychedelic-derived products.

PRISM Emerging Psychedelics IndexInception Date of 1/2/2024 at $100.00% Change (Daily)Current Index Value% Change (Inception)
-0.5%$90.80-9.2%
Index ComponentsTickerCurrent Price% Daily ChangeVolume (1,000s)Average Volume (1,000s)Market Cap (Millions)1/2/2024 Price% Change Since Inception 1/2/2024